Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Balsm Alofoq Medical Co. / 2024 Annual Results

Balsm Alofoq Medical Co. 2024 Annual Results

Revenue
SAR 20M
Net Profit
SAR 5M
EPS
SAR 4.68
Operating Cash Flow
SAR 5M

Balsm Alofoq Medical Co. (9620) reported full year 2024 revenue of SAR 20M. Net profit came in at SAR 5M. Earnings per share were SAR 4.68. The company generated SAR 5M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.15 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.15.

Key Financial Metrics

Metric2024
RevenueSAR 20M
Net ProfitSAR 5M
Net Margin24.1%
ROE16.5%
EPSSAR 4.68
Total AssetsSAR 33M
Total EquitySAR 29M
Total LiabilitiesSAR 4M
Operating Cash FlowSAR 5M

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-03-23.